Dr. Agarwal's Health Care IPO Closed
Already have an account? Apply now
Schedule of Dr. Agarwal's Health Care
| Issue open date | 29 Jan 2025 |
| Issue close date | 31 Jan 2025 |
| UPI mandate deadline | 31 Jan 2025 (5 PM) |
| Allotment finalization | 03 Feb 2025 |
| Refund initiation | 04 Feb 2025 |
| Share credit | 04 Feb 2025 |
| Listing date | 05 Feb 2025 |
| Mandate end date | 13 Feb 2025 |
| Lock-in end date for anchor investors (50%) | 05 Mar 2025 |
| Lock-in end date for anchor investors (remaining) | 04 May 2025 |
Note: The schedule is tentative. The anchor lock-in period ends 30 days after the actual allotment date for 50% of the shares and 90 days after for the remaining portion. The allotment status can be checked on the registrar's website and the exchange website.
About Dr. Agarwal's Health Care
Dr. Agarwal’s Health Care is a leading provider of comprehensive eye care services, offering cataract, refractive, and other surgeries, consultations, diagnoses, and non-surgical treatments, along with opticals, contact lenses, and eye care-related pharmaceutical products. With a 25% market share in India’s eye care service chain market (FY24) and the largest network of 209 facilities as of September 30, 2024, their “hub and spoke” model ensures deeper reach and accessibility. Serving 2.13 million patients and performing over 220,000 surgeries in FY24, Dr. Agarwal’s healthcare caters to diverse needs through Primary, Secondary, and Tertiary Facilities, including three Centers of Excellence. Led by Dr Amar Agarwal and supported by institutional investors like Temasek and TPG, Dr Agarwal’s Health Care operates across 14 states in India and nine countries in Africa.
Financials of Dr. Agarwal's Health Care
Issue size
| Funds Raised in the IPO | Amount |
| Overall | ₹3027.26 crores |
| Fresh Issue | ₹300 crores |
| Offer for Sale | ₹2727.26 crores |
Utilisation of proceeds
| Purpose | INR crores |
| Repayment/prepayment, in part or full, of certain borrowings | 195 |
Strengths
- Largest network of 209 eye care centers in India.
- Strong leadership and operational history.
- Comprehensive services and product offerings.
- Significant market share and growth potential.
Risks
- Dependency on regulatory approvals.
- Intense market competition.
- Financial and debt-related risks.
- Potential legal challenges.
Allotment Status for Dr. Agarwal’s Health Care
To check your allotment status – click here.
Subscription Figures for Dr. Agarwal’s Health Care
Subscription numbers as of 5:00 PM on 31 Jan 2025:
| Category | Reserved (lakhs) | Applied (lakhs) | Subscription (X times) |
|---|---|---|---|
| Institutional | 145.19 | 673.61 | 4.64x |
| HNI (₹2L+) | 108.89 | 42.80 | 0.39x |
| Retail (upto ₹2L) | 254.08 | 103.39 | 0.41x |
| Employees | 15.79 | 4.19 | 0.27x |
| Total | 535.26 | 829.77 | 1.55x |